Chengdu Olymvax Biopharmaceuticals Inc.SSE: 688319

2025 Semi-annual Report

Aug 29, 2025 · Issued by Chengdu Olymvax Biopharmaceuticals Inc. via Shanghai Stock Exchange

Filed with SSE · Aug 29, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-395

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Chengdu Olymvax Biopharmaceuticals Inc. on 6ix

Earlier from Chengdu Olymvax Biopharmaceuticals

Announcement on Abnormal Fluctuations in Stock TradingAug 21, 2025
Indicative Announcement on Disclosure for Issuing RMB Common Shares (A-shares) to Specific Targets through Simplified Procedures (2nd Revised Draft)Aug 19, 2025
Announcement on Adjustment of Key Technical PersonnelJul 31, 2025
Announcement on Resolutions of the 14th Meeting of the 6th Board of SupervisorsJul 15, 2025
Announcement on Dilution of Immediate Return by Issuing A Shares to Specific Objects with Summary Procedures, Remedial Measures and Commitments of Relevant Entities (Revised Edition)Jun 26, 2025

Later from Chengdu Olymvax Biopharmaceuticals

Announcement on Resolutions of the 4th Meeting of the 7th Board of DirectorsSep 1, 2025
Announcement on Shareholding Reduction Plan for Senior Management MembersSep 5, 2025
Announcement on Attending Collective Performance Briefing for Innovative Drug Industry on Semi-annual SSE STAR Market 2025Sep 9, 2025
Announcement on Obtaining Government SubsidiesSep 20, 2025
Indicative Announcement on Planning to Issue H-shares and Listing on the Stock Exchange of Hong Kong LimitedSep 24, 2025

All Chengdu Olymvax Biopharmaceuticals news releases

Follow Chengdu Olymvax Biopharmaceuticals into a list and get an email when it puts out news.

Follow Chengdu Olymvax Biopharmaceuticals